Register Here

Lead Sponsor

Cambridge Design Partnership

Featured Executive Sponsor

Nanoform

Executive Sponsors

BD Medical
Phillips-Medisize

Featured Associate Sponsor

Amneal Pharmaceuticals
Kymanox
Millipore Sigma

Associate Sponsors

Apiject
Credence MedSystems
Flex
pfizer
Pharmacircle

Technology Track Sponsors

Adare Pharma
Aptar
Ascendia Pharma
Battelle
Cleanese
Congruence Medical Solutions
Eitan Medical
Evonik Corporation
Innocore
Isometric Micro Molding
Lubrizol Life Science Health
NOF Corporation
Oakwood Labs
Portal Instruments
ReCode Therapeutics
Secant Group
SeraNovo
SHL Medical
SMC Ltd.
Stevanato Group
ttp
Picocyl

Exhibitors

Baumann
DigiM
Harro Höfliger Verpackungsmaschinen GmbH
H&T Presspart
IGS Gebo Jagema NL
Kinneir Dufort
Paragon Medical
Renishaw
Scherdel Medtech
Shore Group
SOTAX Group
Weidmann Medical Technology
Zenius

Soapbox Sponsor

Piezo Therapeutics

2022 Media Partners

Big 4 Bio
Drug Development and Delivery
Med Device Online
ONdrugDelivery

Supporting Partners

Massachusetts Life Sciences Center
MCD Group

Overview

Partnership Opportunities in Drug Delivery (PODD®) is committed to upholding its tradition of combining partnering, access to cutting-edge business and scientific content in the field of drug delivery, with loyal support from a top notch speaking faculty. PODD provides access to a wide range of drug delivery technologies and partnering before, during, and after the event.

About PODD  

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations. 

 

2022 Co-Chairs, Keynotes and Zeitgeist Speakers

2022 Featured Speakers

 

Key Topic Areas for 2022

  • The Future of RNA Delivery
  • Payer Perspective on Drug Delivery Differentiation
  • Meeting the Demands for At-Home Drug Delivery
  • Combination Product Strategies
  • Subcutaneous Formulations and Technology
  • Oral Delivery of Biologics
  • Adaptive Drug Delivery
  • Next-Generation on Connected Devices
  • Targeted Drug Delivery
  • Connected Devices
  • Challenging the Cost of Drug Delivery Manufacturing

 

Additional Program Features

  • Pharma Company Spotlights on Drug Delivery Needs and Partnering Philosophies
  • Technology Presentations – 7 Tracks Covering a Wide Range of Drug Delivery Technologies
  • Partnering Opportunities that include One-on-One Scheduled Meetings to Help Foster New Collaborations

 

The PODD Promise:

  1. Present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.

  2. Provide drug delivery and specialty pharmas with a platform to present their technologies.

  3. Offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.


Many thanks to the PODD community for a fantastic 2022 conference! For any questions, please contact us at service@tcfllc.org. Thank you.

Sincerely,

 

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith-2018

Meredith Sands
Executive Director, Strategic Partnerships

Andrew Goldstein
Conference Producer

Shelby Casabura
Strategic Partnership Associate

Bre Bugbee
Senior Marketing Manager

Efrosini Zambas
Meeting Planner

Michelle McDermott
Senior Drug Delivery Advisor

Danielle Clarke-Newell
Meeting Planner

 

 

 


Testimonials

  • "Thank you for the excellent organization and guidance of PODD."

    - Beate Bittner, PhD, Roche

  • "First time at PODD. Really nice to see both the needs from pharma companies and the technologies from device companies."

    - Tieming Ruan, Alexion

  • "Thanks for the excellent organization in the virtual setting."

    - Tanjew Dittgen, Boehringer Ingelheim

  • "Terrific talks and panel discussions. I thought the pace of the conference was perfect."

    - Christina Bailey-Hytholt, Sanofi

  • "It was an absolute pleasure to participate in PODD 2020 and be a part of a panel discussion. I really enjoyed it! Moreover, I must commend the organisers for putting together a really nice program and one that worked well in the virtual setting."

    - Stephen T. Buckley, Novo Nordisk

  • "Great job pulling off this event in this format! It could not have been easy and it went off quite smoothly. Again, loved the debut production/format (the intro/music) and speaker introductions help set the tone to kick off the event. "

    - Diane Wheeler, Noble International

  • "The virtual format was the next best thing to being there in person! Simply awesome"

    - A. Neil Jones, Lindy Biosciences Inc.

  • "Incredible! Fantastic overview of the industry, recent, partnerships and opportunities for the future. Helpful input on panels, speaker presentations and what's in the pipeline. Great networking opportunities and sharing insights with colleagues. Hard to choose just one area - was all invaluable."

    - Kristin King, Rogers Sciences

  • "Overall very satisfied. Best was networking, coming across new technologies that I did not necessarily have on the radar, and the speaker’s program."

    - Gregoire Schwach, Roche

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "This was a great partnering event for us. In addition to our product development services, we have a couple of proprietary technologies that we are promoting. The right group of Directors, Exec Dir, VPs were at the meeting who were all looking for delivery technologies."

    - Chris Rhodes, Drug Delivery Experts